MANNKIND CORP Release Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004
EXHIBIT A SEPARATION DATE RELEASE (Tobe signed on or within 45 days after the Separation Date.)
Release Agreements
MANNKIND CORP
Biotechnology
CA
2016
EXHIBIT A SEPARATION DATE RELEASE (To be signed on or within 21 days after the Separation Date.)
Release Agreements
MANNKIND CORP
Biotechnology
CA
2016
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004
Approximates natural first-phase insulin release spike. Typically, regular insulin delivered by subcutaneous injection results in peak insulin levels in about 120 to 180 minutes....
Release Agreements
MANNKIND CORP
2004